RecruitingPhase 3NCT06349941

Home-based Cardiac Rehabilitation in Heart Failure

Implementing a Home-based Cardiac Rehabilitation Program Among Rural Patients With Heart Failure

Sponsor

University of Texas Southwestern Medical Center

Enrollment

332 participants

Start Date

Aug 15, 2025

Study Type

INTERVENTIONAL

Conditions

Heart Failure

Summary

This study evaluates a mobile health (mHealth) home-based cardiac rehabilitation program for patients with heart failure. We will stratify randomization between rural and urban populations, with the goal to assess implementation of cardiac rehabilitation across these two geographic areas. . The study will randomize 332 patients with heart failure (ejection fraction ≥35%) who are not eligible for center-based rehabilitation to either a 12-week mHealth cardiac rehabilitation program or an attention control group, with outcomes measured over 6 months using a composite endpoint of mortality, hospitalizations, and quality of life. We will then assess the implementation of the intervention.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a home-based cardiac rehabilitation program — delivered through a smartphone app with telemedicine visits — for people who were recently hospitalized for heart failure, to see if it helps them recover better than usual care. **You may be eligible if...** - You are 18 or older - You were recently hospitalized for heart failure and your heart's pumping function is at least 35% - You own a smartphone or tablet capable of running the health app - You are able to attend telemedicine (video or phone) visits - You are willing to participate in a home exercise and rehabilitation program **You may NOT be eligible if...** - Your heart failure is severe with a pumping function below 35% - You have a medical condition that prevents you from exercising - You do not have access to a smartphone or the internet - Your life expectancy is less than 6 months - You are already enrolled in another cardiac rehabilitation program Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMovn app

Participants will have 12-week home-based exercise program delivered via a commercially available home-based cardiac rehabilitation platform called Movn. The plan includes an accelerometer, blood pressure scale, and mobile application.

DEVICEAccelerometer

Participants will receive a FitBit for monitoring of physical function.

Locations(2)

University of Texas Southwestern Medical Center

Dallas, Texas, United States

Baylor Scott and White Health System

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06349941

Related Trials

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

NCT06935370638 locations

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

NCT06424288653 locations

Impact of Optimized Pacing Strategies on Clinical and Hemodynamic Outcomes in Heart Failure Patients With Pacemaker

NCT075631531 location

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

NCT06991257135 locations

The Salt Study for Heart Failure

NCT075605921 location